HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
HNRNPU
heterogeneous nuclear ribonucleoprotein U
Chromosome 1 Β· 1q44
NCBI Gene: 3192Ensembl: ENSG00000153187.22HGNC: HGNC:5048UniProt: Q00839
523PubMed Papers
21Diseases
0Drugs
150Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedHub GeneTranscription Factor
RESEARCH IMPACT
Highly StudiedTrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
nucleoplasmpositive regulation of attachment of mitotic spindle microtubules to kinetochoreprotein localization to spindle microtubulenegative regulation of stem cell differentiationdevelopmental and epileptic encephalopathy, 54Epileptic encephalopathyIntellectual disabilitygenetic developmental and epileptic encephalopathy
✦AI Summary

HNRNPU (heterogeneous nuclear ribonucleoprotein U) is a multifunctional RNA-binding protein that plays critical roles in neurodevelopment and cellular regulation. The protein functions as a splicing factor that controls alternative splicing of key transcription factors, including TEAD1, where HNRNPU inhibition leads to exclusion of inhibitory exons and increased TEAD1 activity 1. HNRNPU also regulates NF-ΞΊB signaling through direct interaction with FOXN3, competing with IΞΊBΞ± binding and modulating inflammatory responses 2. Loss-of-function mutations in HNRNPU are strongly associated with neurodevelopmental disorders, particularly developmental and epileptic encephalopathy 34. De novo HNRNPU mutations contribute significantly to autism spectrum disorders and epileptic encephalopathies, with the gene showing enrichment for damaging mutations in affected individuals 56. In cancer, HNRNPU expression correlates with cisplatin resistance in bladder cancer, where its knockout enhances chemosensitivity by affecting DNA damage repair pathways and NF1 regulation 7. The protein demonstrates high expression in radial glial progenitors during cerebral cortical development, supporting its critical role in neurodevelopmental processes 6.

Sources cited
1
HNRNPU functions as a splicing factor controlling TEAD1 alternative splicing
PMID: 38670107
2
HNRNPU regulates NF-ΞΊB signaling through FOXN3 interaction
PMID: 36794705
3
HNRNPU mutations are associated with neurodevelopmental disorders
PMID: 33004838
4
De novo HNRNPU mutations found in epileptic encephalopathies
PMID: 23934111
5
HNRNPU mutations contribute to autism spectrum disorder risk
PMID: 28714951
6
HNRNPU shows enriched expression in radial glial progenitors during neurodevelopment
PMID: 33874999
7
HNRNPU expression correlates with cisplatin resistance in bladder cancer
PMID: 35130920
Disease Associationsβ“˜21
developmental and epileptic encephalopathy, 54Open Targets
0.79Strong
Epileptic encephalopathyOpen Targets
0.64Moderate
Intellectual disabilityOpen Targets
0.58Moderate
genetic developmental and epileptic encephalopathyOpen Targets
0.57Moderate
neurodegenerative diseaseOpen Targets
0.53Moderate
genetic disorderOpen Targets
0.52Moderate
SeizureOpen Targets
0.49Moderate
complex neurodevelopmental disorderOpen Targets
0.40Weak
dengue diseaseOpen Targets
0.37Weak
Neurodevelopmental delayOpen Targets
0.34Weak
Neurodevelopmental disorderOpen Targets
0.27Weak
CachexiaOpen Targets
0.21Weak
neoplasmOpen Targets
0.10Weak
gastric cancerOpen Targets
0.10Suggestive
gliomaOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.08Suggestive
acute myeloid leukemiaOpen Targets
0.08Suggestive
viral diseaseOpen Targets
0.08Suggestive
triple-negative breast cancerOpen Targets
0.07Suggestive
oral squamous cell carcinomaOpen Targets
0.06Suggestive
Developmental and epileptic encephalopathy 54UniProt
Pathogenic Variants150
NM_031844.3(HNRNPU):c.1142dup (p.Tyr381Ter)Likely pathogenic
Neurodevelopmental disorder|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2026β†’ Residue 381
NM_031844.3(HNRNPU):c.643_652del (p.Lys215fs)Pathogenic
Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2026β†’ Residue 215
NM_031844.3(HNRNPU):c.1780_1781del (p.Cys594fs)Pathogenic
Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2026β†’ Residue 594
NM_031844.3(HNRNPU):c.481C>T (p.Gln161Ter)Pathogenic
Developmental and epileptic encephalopathy, 54|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 161
NM_031844.3(HNRNPU):c.625C>T (p.Gln209Ter)Pathogenic
Developmental and epileptic encephalopathy, 54|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 209
NM_031844.3(HNRNPU):c.1714C>T (p.Arg572Ter)Pathogenic
Epileptic encephalopathy|Intellectual disability;Seizure|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 572
NM_031844.3(HNRNPU):c.804-9_804-6delPathogenic
Developmental and epileptic encephalopathy, 54|not provided
β˜…β˜…β˜†β˜†2025
NM_031844.3(HNRNPU):c.1429C>T (p.Gln477Ter)Pathogenic
not provided|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2024β†’ Residue 477
NM_031844.3(HNRNPU):c.803G>A (p.Arg268Lys)Likely pathogenic
not provided|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2024β†’ Residue 268
NM_031844.3(HNRNPU):c.2425-2A>GPathogenic
Developmental and epileptic encephalopathy, 54|not provided
β˜…β˜…β˜†β˜†2024
NM_031844.3(HNRNPU):c.2304_2305del (p.Gly769fs)Pathogenic
Intellectual disability and seizures|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2022β†’ Residue 769
NM_031844.3(HNRNPU):c.16delinsATT (p.Val6fs)Pathogenic
Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2022β†’ Residue 6
NM_031844.3(HNRNPU):c.520C>T (p.Gln174Ter)Pathogenic
not provided|Developmental and epileptic encephalopathy, 54|HNRNPU-related disorder
β˜…β˜…β˜†β˜†2022β†’ Residue 174
NM_031844.3(HNRNPU):c.1060_1061del (p.Asp353_Ile354insTer)Pathogenic
not provided|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2022β†’ Residue 353
NM_031844.3(HNRNPU):c.2319_2320del (p.Gly774fs)Likely pathogenic
not provided
β˜…β˜…β˜†β˜†2021β†’ Residue 774
NM_031844.3(HNRNPU):c.191_206del (p.Gly64fs)Pathogenic
not provided|Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2020β†’ Residue 64
NM_031844.3(HNRNPU):c.2270_2271del (p.Pro757fs)Pathogenic
Epileptic encephalopathy|not provided
β˜…β˜…β˜†β˜†2020β†’ Residue 757
NM_031844.3(HNRNPU):c.1681dup (p.Gln561fs)Pathogenic
Developmental and epileptic encephalopathy, 54
β˜…β˜…β˜†β˜†2020β†’ Residue 561
NM_031844.3(HNRNPU):c.1852C>T (p.Gln618Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2018β†’ Residue 618
NM_031844.3(HNRNPU):c.2234dup (p.Ser746fs)Likely pathogenic
Developmental and epileptic encephalopathy, 54
β˜…β˜†β˜†β˜†2026β†’ Residue 746
View on ClinVar β†—
Related Genes
SNRPBProtein interaction100%SNRPEProtein interaction100%PRMT8Protein interaction100%ILF3Protein interaction100%IGF2BP1Protein interaction99%ELAVL1Protein interaction97%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
84%
Ovary
44%
Heart
34%
Lung
32%
Liver
23%
Gene Interaction Network
Click a node to explore
HNRNPUSNRPBSNRPEPRMT8ILF3IGF2BP1ELAVL1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q00839
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.11Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.04 [0.02–0.11]
RankingsWhere HNRNPU stands among ~20K protein-coding genes
  • #495of 20,598
    Most Researched523 Β· top 5%
  • #505of 5,498
    Most Pathogenic Variants150 Β· top 10%
  • #89of 17,882
    Most Constrained (LOEUF)0.11 Β· top 1%
Genes detectedHNRNPU
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
PMID: 33004838
Nat Commun Β· 2020
1.00
2
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis.
PMID: 38670107
Cell Metab Β· 2024
0.90
3
De novo mutations in moderate or severe intellectual disability.
PMID: 25356899
PLoS Genet Β· 2014
0.86
4
FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression.
PMID: 37915048
J Exp Clin Cancer Res Β· 2023
0.80
5
De novo mutations in epileptic encephalopathies.
PMID: 23934111
Nature Β· 2013
0.80